COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries.
Eng Hooi TanAnthony G SenaAlbert Prats-UribeSeng Chan YouWaheed-Ul-Rahman AhmedKristin KostkaChristian ReichScott L DuvallKristine E LynchMichael E MathenyTalita Duarte-SallesSergio Fernandez BertolinGeorge HripcsakKarthik NatarajanThomas FalconerMatthew SpotnitzAnna OstropoletsClair BlacketerThamir M AlshammariHeba AlghoulOsaid AlserJennifer C E LaneDalia M DawoudKarishma ShahYue YangLin ZhangCarlos AreiaAsieh GolozarMartina RecaldePaula CasajustJitendra JonnagaddalaVignesh SubbianDavid VizcayaLana Y H LaiFredrik NybergDaniel R MoralesJose D PosadaNigam H ShahMengchun GongArani VivekananthamAaron AbendEvan P MintyMarc SuchardPeter RijnbeekPatrick B RyanDaniel Prieto-AlhambraPublished in: Rheumatology (Oxford, England) (2021)
Compared with influenza, COVID-19 is a more severe disease, leading to more complications and higher mortality.